Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Acidos Grasos
Acidos Grasos
vhnhvh
Richardson, A.J. et al., Long chain polyunsaturated fatty acids in childhood developmental
and psychiatric disorders (2004) Lipids, Vol. 39, 12: 1215-1222.
2. Prensky A.L., Nutritional deficiency and the nervous system, en Berg B.O. (ed.),
Principles of child neurology, New York: McGraw-Hill, 1996: 1249-77.
3. Sinn N., Bryan J., Effect of Supplementation with Polyunsaturated Fatty Acids and
Micronutrients on Learning and Behavior Problems Associated with Child ADHD, en (2007)
J. Dev Behav. Pediatr., Vol. 28: 8291.
4. Somatic treatment of bipolar disorder in children and adolescents, Elizabeth B. Weller
M.D., Psychiatr Clin. N. Am. 27 (2004): 155178.
5. Richardson A.J. Omega 3 fatty acids in ADHD and related neurodevelopment disorders,
en Rev. Psychiatry, 2006, Apr., 18(2): 155-72.
6. Richardson O, et al., The Oxford-Durham Study: A randomized, controlled trial of dietary
supplementation with fatty acids in children with developmental coordination disorder.
(2005) Pediatrics, Vol, 115, No. 5, May: 1360-1366.
7. Baker R.D. et al., Long chain polyunsaturated fatty acids in chronic childhood disorders:
Panacea, Promising, or placebo. (2004). Journal of Pediatric Gastroenterology and
Nutrition, 38: 2-3.
8. Busch et al., Polyunsaturated fatty acid supplementation for ADHD? Fishy, fascinating,
and far from clear. (2007), Journal of Developmental and Behavioral Pediatrics, Vol. 28: 2.
9. Kidd PM, et al., An approach to the nutritional management of autism, in. Alternatives
Therapies in Health and Medicine, Sep.-Oct. 2003, Vo.l 9, No. 5: 22-31.
10. Carton, N., et al., Diet intervention and autism- Implementing the gluten free casein free
diet. Tizard learning disability review, Jul. 2005; 10, 3; ProQuest Nursing and allied health
ource: 42-43.
11. Faraone S.V., Sergeant J., Gillberg C., Biederman J. (2003): The worldwide prevalence
of ADHD: Is it an american condition? World Psychiatry 2: 104-113.
12. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental
Disorders, 4th ed. Washington, D.C.: American Psychiatric Association.
13. Barragn-Prez, Pea-Olvera et al., Primer consenso latinoamericano de trastorno por
dficit de atencin e hiperactividad (2007), Bol. Med. Hosp. Infant. Mex., 64 (5): 326-343.
14. Perlov E., Philipsen A. et al., Spectroscopic findings in attention-deficit/hyperactivity
disorder: Review and meta-analysis. The World Journal of Biological Psychiatry, 2008: 111, first article.
15. Lora Espinosa A., El tratamiento del nio y adolescente con TDAH en Atencin
Primaria desde el punto de vista de la evidencia (2006), Revista Pediatra de Atencin
Primaria, Vol. VIII, Suplemento 4.
16. Konrad K., Neufang S., Hanisch C., Fink G.R., Herpertz-Dahlmann B., Dysfunctional
31. Allain, P., Mauras. Y., Premel-Cabic A. et al., Effects of an EDTA infusion on the urinary
elimination of several elements in healthy subjects, Br. J. Clin. Pharmacol, 1991, 31: 347.
32. Yuen, W.C., Whiteoak, R., Thompson, R.P., Zinc concentrations in leucocytes of
patients receiving antiepileptic drugs, J. Clin. Pathol., 1998, 41: 553-5.
33. Ozutemiz AO, Aydin HH, Isler M, et al. Effect of omeprazole on plasma zinc levels after
oral zinc administration, Ind. J. Gastroenterol, 2002, 21: 216-8.
34. Sweeney, J.D., Ziegler, P., Pruet, C., Spaulding, M.B., Hyperzincuria and hypozincemia
in patients treated with cisplatin, Clin. Nephro.,l 1982, 17: 254-7.
35. Penttila, O., Hurme, H., Neuvonen, P.J., Effect of zinc sulfate on the absorption of
tetracycline and doxycycline in man, Eur. J. Clin. Pharmacol., 1975, 9:131-4.
36. Agte. V.V., Chiplonkar, S.A., Gokhale, M.K., Interaction of riboflavin with zinc
bioavailability, Ann. N.Y. Acad. Sci., 1992, 669: 314-6.
37. Botash, A.S., Nasca J, Dubowy, R., et al., Zinc-induced copper deficiency in an infant,
Am. J. Dis. Child., 1992, 146: 709-11
38. Wood, R.J., Zheng, J.J., High dietary calcium intakes reduce zinc absorption and
balance in humans, Am. J. Clin. Nutr., 1997, 65: 1803-9.
39. Bilici, M., Yildirim, F., Kandil, S. et al., Double-blind, placebo-controlled study of zinc
sulfate in the treatment of attention deficit hyperactivity disorder, Prog.
Neuropsychopharmacol. Biol. Psychiatry, 2004, 28: 181-90.
40. Lopez de Romana, D., Lonnerdal, B., Brown, K.H., Absorption of zinc from wheat
products fortified with iron and either zinc sulfate or zinc oxide, Am. J.Clin. Nutr., 2003, 78:
279-83.
41. Leitzmann, M.F., Stampfer, M.J., Wu, K. et al., Zinc supplement use and risk of prostate
cancer, J. Natl. Cancer Inst., 2003, 95: 1004-7.
42. Arnold, L.E., Votolato, N.A., Kleykamp, D. et al., Does hair zinc predict amphetamine
improvement of ADD/hyperactivity?, Int. J. Neurosci., 1990, 50: 103-7.
43. Toren, P., Eldar, S., Sela, B.A. et al., Zinc deficiency in attention-deficit hyperactivity
disorder, Biol. Psychiatry, 1996, 40: 1308-10.
44. Bekaroglu, M., Aslan, Y., Gedik, Y. et al., Relationships between serum free fatty acids
and zinc, and attention deficit hyperactivity disorder: a research note, J. Child. Psychol.
Psychiatry, 1996, 37: 225-7.
45. Donangelo, C.M., Woodhouse, L.R., King, S.M. et al., Supplemental zinc lowers
measures of iron status in young women with low iron reserves, J. Nutr.,2002, 132: 1860-4.
46. Sazawal, S., Black, R.E., Menon, V.P. et al., Zinc supplementation in infants born small
for gestational age reduces mortality: a prospective, randomized, controlled trial, Pediatrics
2001, 108: 1280-6.
47. Bhutta, Z.A., Bird, S.M., Black, R.E. et al., Therapeutic effects of oral zinc in acute and
persistent diarrhea in children in developing countries: pooled analysis of randomized
controlled trials, Am. J. Clin. Nutr., 2000, 72: 1516-22.
48. King, J.C., Enhanced zinc utilization during lactation may reduce maternal and infant
zinc depletion, Am. J. Clin. Nutr., 2002, 75: 2-3.
49. Freake, H.C., Govoni, K.E., Guda, K. et al., Actions and interactions of thyroid hormone
and zinc status in growing rats, J. Nutr., 2001, 4: 1135-41.
50. Whittaker, P., Iron and zinc interactions in humans, Am. J. Clin. Nutr., 1998, 68: 442S6S.
51. Katz, R.L., Keen, C.L., Litt, I.F., et al., Zinc deficiency in anorexia nervosa, J. Adolesc.
Health Care, 1987, 8: 400-6.
52. Mahajan, S.K., Prasad, A.S., Lambujon J. et al., Improvement of uremic hypogeusia by
zinc: a double-blind study, Am. J. Clin. Nutr., 1980, 33: 1517-21.
53. Ripamont,i C., Zecca, E., Brunell,i C., et al., A randomized, controlled clinical trial to
evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head
and neck irradiation, Cancer, 1998, 82: 1938-45.
54. Henkin, R.I., Schecter, P.J., Friedewald, W.T. et al., A double-blind study of the effects of
zinc sulfate on taste and smell dysfunction, Am. J. Med. Sci., 1976, 272: 285-99.
55. Zavaleta, N., Caulfield, L.E., Garcia, T., Changes in iron status during pregnancy in
peruvian women receiving prenatal iron and folic acid supplements with or without zinc,
Am. J. Clin. Nutr., 2000, 71: 956-61.
56. Dvorkov, M., Sivonov, M., Trebatick, J., Skodcek, I., Waxzulikov, I., Muchov, J.
et al., The effect of polyphenolic extract from pine bark, pycnogenol on the level of
glutathione in children suffering from attention defict hyperactivity disorder (ADHD), Redox
Rep., 2006, 11(4): 163-72.
57. DAdrea, G., Pygcnogenol: a blend of procyanidins with multifaceted therapeutic
applicarions?, Fitoterapia, 2010, 81(7): 724-36.
58. Chovanov, Z., Muchov, J., Sivonov, M., Dvorkov, M., Zitnanov, I., Waczulkov,
I. et al., Effect of polyphenolic extrac, Pycnogenol, on the level of 8- oxoguanine in children
suffering attention defict/hyperactivity disorder, Free Radic Res., 2006, 40(9): 1003-10.
59. Dvorkov, M., Jezov, D., Blazicek, P., Trebatick, J., Skodcek, I., Suba, J. et al.,
Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD):
modulation by a polyphenolic extrac from pine bark (pycnogenol), Nutr. Neurosci., 2007,
10(3-4): 151-7.
60. Trebatick, J., Kopasov, S., Hradecn, Z., Cinovsk, K., Skodcek, I., Sub, J. et al.,
Treatment of ADHD with French maritime pine bark extract, Pycnogenol, Eur. Child
Adolesc. Psychiatry, 2006, 15(6): 329-35.
61. Rohdewald, P., A review of the French maritime pine bark extract (Pycnogenol), a
herbal medication whit a diverse clinical pharmacology), Int. .J clin. Pharmacol. Ther., 2002,
40(4): 158-68.
62. Sarri, J., Complementary medicines (herbal an nutritional products) in the treatment of
Attention Defict hyperactivity Disorder (ADHD): A systematic review of the evidence,
Complement Ther. Med., 2011, 19(4): 216-218.